← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 31, 2017Last known activity
Jun 2, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 7 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT05913921Overall official - principal investigatorPhase 1Jun 2, 2023
- NCT05777109Overall official - principal investigatorPhase 1Apr 20, 2023
- NCT04468529Overall official - principal investigatorPhase 3Dec 30, 2020
- NCT04150835CollaboratorPhase 4Nov 30, 2019
- NCT05528198Overall official - principal investigatorN/ADec 28, 2018
- NCT05531994Overall official - principal investigatorN/ANov 27, 2018
- NCT03236636CollaboratorPhase 3Aug 31, 2017
Details
- Last known activity
- Jun 2, 2023